The inhibition of protein-carbohydrate interaction provides a powerful ther
apeutic strategy for the treatment of myriad human diseases. To date, appli
cation of such approaches have been frustrated by the inherent low affinity
of carbohydrate ligands for their protein receptors. Because lectins typic
ally exist in multimeric assemblies, a variety of polyvalent saccharide lig
ands have been prepared in the search for high affinity. The cluster glycos
ide effect, or the observation of high affinity derived from multivalency i
n oligosaccharide Ligands, apparently represents the best strategy for over
coming the "weak binding" problem. Here we report the synthesis of a series
of multivalent dendritic saccharides and a biophysical evaluation of their
interaction with the plant lectin concanavalin A. Although a 30-fold enhan
cement in affinity on a valence-corrected basis is observed by agglutinatio
n assay, calorimetric titration of soluble protein with a range of multival
ent ligands reveals no enhancement in binding free energies. Rather, IC50 v
alues from agglutination measurements correlate well with entropies of bind
ing. This observation suggests that hemagglutination measures a phenomenon
distinct from binding that is typified by a large favorable entropy and an
unfavorable enthalpy: this process is almost certainly aggregation. Support
ing this assertion, we report crystal structures of multivalent ligands cro
ss-linking concanavalin A dimers. To the best of our knowledge, these struc
tures are the first reported of their kind. Our results indicate that hemag
glutination assays evaluate the ability of ligands to inhibit the formation
of cross-linked lattices, a process only tangentially related to reversibl
e ligand binding. Cluster glycoside effects observed in agglutination assay
s must, therefore, be viewed with caution. Such effects may or may not be r
elevant to the design of therapeutically useful saccharides.